Found: 320
Select item for more details and to access through your institution.
Measurement error and bias in real-world oncology endpoints when constructing external control arms.
- Published in:
- Frontiers in Drug Safety & Regulation, 2024, p. 1, doi. 10.3389/fdsfr.2024.1423493
- By:
- Publication type:
- Article
Effectiveness and safety of empagliflozin: final results from the EMPRISE study.
- Published in:
- Diabetologia, 2024, v. 67, n. 7, p. 1328, doi. 10.1007/s00125-024-06126-3
- By:
- Publication type:
- Article
Data Checks Before Registering Study Protocols for Health Care Database Analyses.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
Emulation of randomized trials of direct oral anticoagulants with claims data and implications for new Factor XI inhibitors.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5813
- By:
- Publication type:
- Article
Hypothetical Assessments of Trial Emulations.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Validation of alopecia coding in US claims data among women of childbearing age.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 4, p. 1, doi. 10.1002/pds.5782
- By:
- Publication type:
- Article
Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02190-6
- By:
- Publication type:
- Article
Prevalence of Pretreatment Testing Recommended for Patients With Chronic Inflammatory Skin Diseases.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 3, p. 334, doi. 10.1001/jamadermatol.2023.5895
- By:
- Publication type:
- Article
Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02150-0
- By:
- Publication type:
- Article
High‐Dose vs. Standard‐Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 1, p. 126, doi. 10.1002/cpt.3080
- By:
- Publication type:
- Article
Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023.
- Published in:
- Drug Safety, 2024, v. 47, n. 1, p. 103, doi. 10.1007/s40264-023-01362-9
- By:
- Publication type:
- Article
Stratified analysis in comparative effectiveness studies that emulate randomized trials.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 1, p. 1, doi. 10.1002/pds.5716
- By:
- Publication type:
- Article
The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 11, p. 2609, doi. 10.1007/s13555-023-01023-w
- By:
- Publication type:
- Article
Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes.
- Published in:
- Diabetes Care, 2023, v. 46, n. 11, p. 2004, doi. 10.2337/dc23-0671
- By:
- Publication type:
- Article
Predicting Treatment Effects of a New‐to‐Market Drug in Clinical Practice Based on Phase III Randomized Trial Results.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 853, doi. 10.1002/cpt.2983
- By:
- Publication type:
- Article
Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic Review.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 9, p. e2336023, doi. 10.1001/jamanetworkopen.2023.36023
- By:
- Publication type:
- Article
Understanding the Facets of Emulating Randomized Clinical Trials—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 8, p. 770, doi. 10.1001/jama.2023.11535
- By:
- Publication type:
- Article
Antidiabetes medication initiation trends in US adults with cirrhosis and type 2 diabetes: A nationwide study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 2028, doi. 10.1111/dom.15052
- By:
- Publication type:
- Article
Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 4, p. 543, doi. 10.1007/s11523-023-00979-1
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2216, doi. 10.1093/eurheartj/ehad273
- By:
- Publication type:
- Article
The Aetion Coalition to Advance Real‐World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 6, p. 1217, doi. 10.1002/cpt.2800
- By:
- Publication type:
- Article
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 5, p. 567, doi. 10.1002/pds.5586
- By:
- Publication type:
- Article
Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 16, p. 1376, doi. 10.1001/jama.2023.4221
- By:
- Publication type:
- Article
Scalable Feature Engineering from Electronic Free Text Notes to Supplement Confounding Adjustment of Claims‐Based Pharmacoepidemiologic Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 4, p. 832, doi. 10.1002/cpt.2826
- By:
- Publication type:
- Article
Effectiveness research in oncology with electronic health record data: A retrospective cohort study emulating the PALOMA‐2 trial.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 4, p. 426, doi. 10.1002/pds.5565
- By:
- Publication type:
- Article
Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative Datasets.
- Published in:
- Clinical Epidemiology, 2023, v. 15, p. 349, doi. 10.2147/CLEP.S387253
- By:
- Publication type:
- Article
Risk of Infection in Children With Psoriasis Receiving Treatment With Ustekinumab, Etanercept, or Methotrexate Before and After Labeling Expansion.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 3, p. 289, doi. 10.1001/jamadermatol.2022.6325
- By:
- Publication type:
- Article
Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 3, p. 1, doi. 10.1161/JAHA.122.026863
- By:
- Publication type:
- Article
High‐dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 2, p. 93, doi. 10.1002/pds.5566
- By:
- Publication type:
- Article
Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis.
- Published in:
- Pediatric Dermatology, 2023, v. 40, n. 1, p. 132, doi. 10.1111/pde.15172
- By:
- Publication type:
- Article
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real‐world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 1, p. 44, doi. 10.1002/pds.5507
- By:
- Publication type:
- Article
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors Versus Metformin.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 12, p. W155, doi. 10.7326/L22-0333
- By:
- Publication type:
- Article
Statin Use and Severe Acute Liver Injury Among Patients with Elevated Alanine Aminotransferase.
- Published in:
- Clinical Epidemiology, 2022, v. 14, p. 1535, doi. 10.2147/CLEP.S385712
- By:
- Publication type:
- Article
Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study.
- Published in:
- Diabetes Care, 2022, v. 45, n. 12, p. 2907, doi. 10.2337/dc22-1174
- By:
- Publication type:
- Article
No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study.
- Published in:
- Brain Communications, 2022, v. 4, n. 5, p. 1, doi. 10.1093/braincomms/fcac247
- By:
- Publication type:
- Article
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 5, p. 692, doi. 10.1111/bjd.21704
- By:
- Publication type:
- Article
Advancing an Algorithm for the Identification of Patients with High Data-Continuity in Electronic Health Records.
- Published in:
- Clinical Epidemiology, 2022, v. 14, p. 1339, doi. 10.2147/CLEP.S370031
- By:
- Publication type:
- Article
Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1140, doi. 10.1002/pds.5529
- By:
- Publication type:
- Article
Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 10, p. e2237606, doi. 10.1001/jamanetworkopen.2022.37606
- By:
- Publication type:
- Article
Oncology Drug Effectiveness from Electronic Health Record Data Calibrated Against RCT Evidence: The PARSIFAL Trial Emulation.
- Published in:
- Clinical Epidemiology, 2022, v. 14, p. 1135, doi. 10.2147/CLEP.S373291
- By:
- Publication type:
- Article
Sacubitril/valsartan use patterns among older adults with heart failure in clinical practice: a population‐based cohort study of >25 000 Medicare beneficiaries.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 9, p. 1506, doi. 10.1002/ejhf.2572
- By:
- Publication type:
- Article
Durability of Protection Post–Primary COVID-19 Vaccination in the United States.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1458, doi. 10.3390/vaccines10091458
- By:
- Publication type:
- Article
Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32310-3
- By:
- Publication type:
- Article
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: A Multisite Population-Based Cohort Study.
- Published in:
- American Journal of Epidemiology, 2022, v. 191, n. 8, p. 1352, doi. 10.1093/aje/kwac021
- By:
- Publication type:
- Article
Real-World Evidence Prediction of a Phase IV Oncology Trial: Comparative Degarelix vs Leuprolide Safety.
- Published in:
- JNCI Cancer Spectrum, 2022, v. 6, n. 4, p. 1, doi. 10.1093/jncics/pkac049
- By:
- Publication type:
- Article
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of longitudinal data-completeness of electronic health record data on risk score misclassification.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Evolving channeling in prescribing SGLT‐2 inhibitors as first‐line treatment for type 2 diabetes.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 5, p. 566, doi. 10.1002/pds.5406
- By:
- Publication type:
- Article
Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 4, p. e226567, doi. 10.1001/jamanetworkopen.2022.6567
- By:
- Publication type:
- Article
A Framework for Visualizing Study Designs and Data Observability in Electronic Health Record Data.
- Published in:
- Clinical Epidemiology, 2022, v. 14, p. 601, doi. 10.2147/CLEP.S358583
- By:
- Publication type:
- Article